AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and TencentLeading technology investors back Intelligent Digital Drug Discovery and Development startup for faster, smarter pharmaceutical research SHENZHEN, China, January 23, 2018-- XtalPi Inc., a computation-driven pharmaceutical technology company, announced today that it has closed a Series B funding round of 15 million USD led by Sequoia China, with participation from Google and existing investor Tencent. To date, XtalPi has raised over 20 million USD, making it one of the top-funded AI-powered biotechs.